Pregabalin Capsule
Product Images NDC 69238-1313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 69238-1313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Pregabalin Capsules 1)

FDA Label Image

F-8 (Pregabalin Capsules 10)

FDA Label Image

Fig-9 (Pregabalin Capsules 11)

FDA Label Image

F-10 (Pregabalin Capsules 12)

FDA Label Image

F-11 (Pregabalin Capsules 13)

FDA Label Image

1 (Pregabalin Capsules 14)

FDA Label Image

1 (Pregabalin Capsules 15)

FDA Label Image

1 (Pregabalin Capsules 16)

1 (Pregabalin Capsules 16)
This appears to be a medication guide for Pregabalin capsules, with the NDC number 69238-1312-9, available on the website amneal.com/mg/pregabalin-capsuies or by scanning a QR code. The guide includes dosage information, precautions, and possible side effects. It also advises pharmacists to dispense a copy of the guide to each patient.*
FDA Label Image

1 (Pregabalin Capsules 17)

FDA Label Image

1 (Pregabalin Capsules 18)

FDA Label Image

1 (Pregabalin Capsules 19)

FDA Label Image

Structure (Pregabalin Capsules 2)

FDA Label Image

1 (Pregabalin Capsules 20)

1 (Pregabalin Capsules 20)
Not available.*
FDA Label Image

1 (Pregabalin Capsules 21)

1 (Pregabalin Capsules 21)
Not available.*
FDA Label Image

F1 (Pregabalin Capsules 3)

FDA Label Image

F-2 (Pregabalin Capsules 4)

FDA Label Image

F-3 (Pregabalin Capsules 5)

FDA Label Image

F-4 (Pregabalin Capsules 6)

FDA Label Image

F-5 (Pregabalin Capsules 7)

F-5 (Pregabalin Capsules 7)
This is a graph showing the percentage improvement in pain of patients who received either 100mg of Gabapentin three times a day, 50mg of Pregabalin three times a day or a placebo. The graph shows that both Gabapentin and Pregabalin had a significant impact on improving pain in patients compared to the placebo, with Gabapentin having the highest percentage of improvement. The y-axis shows the percentage improvement and the x-axis shows the time periods in weeks.*
FDA Label Image

F-6 (Pregabalin Capsules 8)

FDA Label Image

F-7 (Pregabalin Capsules 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.